These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38115683)

  • 21. Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes.
    Zhou W; He Z; Xue J; Wang M; Zha X; Ling L; Chen L; Wang S; Liu X
    PLoS One; 2012; 7(4):e35881. PubMed ID: 22563412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a prediction model based on LASSO regression to evaluate the risk of non-sentinel lymph node metastasis in Chinese breast cancer patients with 1-2 positive sentinel lymph nodes.
    Meng L; Zheng T; Wang Y; Li Z; Xiao Q; He J; Tan J
    Sci Rep; 2021 Oct; 11(1):19972. PubMed ID: 34620978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis.
    Ryu JM; Lee SK; Kim JY; Yu J; Kim SW; Lee JE; Han SH; Jung YS; Nam SJ
    Clin Breast Cancer; 2017 Nov; 17(7):550-558. PubMed ID: 28454926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and prognosis of sentinel lymph node metastasis in breast-conserving breast cancer: A retrospective study based on the SEER database.
    Liu R; Chen J; Cao W; Li T; Liao Y; Li Y
    Medicine (Baltimore); 2024 Mar; 103(9):e37263. PubMed ID: 38428869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of a predictive model of axillary lymph node status in patients with sentinel node metastasis from breast cancer. A retrospective cohort study.
    Vieni S; Graceffa G; La Mendola R; Latteri S; Cordova A; Latteri MA; Cipolla C
    Int J Surg; 2016 Nov; 35():58-63. PubMed ID: 27633450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
    Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
    Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine Learning Model for Predicting Axillary Lymph Node Metastasis in Clinically Node Positive Breast Cancer Based on Peritumoral Ultrasound Radiomics and SHAP Feature Analysis.
    Wang SR; Cao CL; Du TT; Wang JL; Li J; Li WX; Chen M
    J Ultrasound Med; 2024 Sep; 43(9):1611-1625. PubMed ID: 38808580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
    Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
    Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
    Reynders A; Brouckaert O; Smeets A; Laenen A; Yoshihara E; Persyn F; Floris G; Leunen K; Amant F; Soens J; Van Ongeval C; Moerman P; Vergote I; Christiaens MR; Staelens G; Van Eygen K; Vanneste A; Van Dam P; Colpaert C; Neven P
    Breast; 2014 Aug; 23(4):453-9. PubMed ID: 24768478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
    Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
    BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?
    Osorio-Silla I; Gómez Valdazo A; Sánchez Méndez JI; York E; Díaz-Almirón M; Gómez Ramírez J; Rivas Fidalgo S; Oliver JM; Álvarez CM; Hardisson D; Díaz Miguel M; Lobo F; Díaz Domínguez J
    Ann R Coll Surg Engl; 2019 Mar; 101(3):186-192. PubMed ID: 30421628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors to assess non-sentinel lymph node status in breast cancer patients with only one sentinel lymph node metastasis.
    Yang B; Yang L; Zuo WS; Ge WK; Zheng G; Zheng MZ; Yu ZY; Wang YS
    Chin Med J (Engl); 2013 Feb; 126(3):476-81. PubMed ID: 23422110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node].
    Huang J; Chen X; Fei X; Huang O; Wu J; Zong Y; Zhu L; He J; Chen W; Li Y; Shen K
    Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):941-6. PubMed ID: 26850667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molybdenum target mammography-based prediction model for metastasis of axillary sentinel lymph node in early-stage breast cancer.
    Yuan C; Xu G; Zhan X; Xie M; Luo M; She L; Xue Y
    Medicine (Baltimore); 2023 Oct; 102(42):e35672. PubMed ID: 37861524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantitative analysis of tumour characteristics in breast cancer patients with extranodal extension in non-sentinel nodes.
    O'Keeffe NA; O'Neill C; Zahere A; Livingstone V; Browne TJ; Redmond HP; Corrigan MA
    Breast; 2018 Apr; 38():171-174. PubMed ID: 29413405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.
    Kohrt HE; Olshen RA; Bermas HR; Goodson WH; Wood DJ; Henry S; Rouse RV; Bailey L; Philben VJ; Dirbas FM; Dunn JJ; Johnson DL; Wapnir IL; Carlson RW; Stockdale FE; Hansen NM; Jeffrey SS;
    BMC Cancer; 2008 Mar; 8():66. PubMed ID: 18315887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging features of sentinel lymph node mapped by multidetector-row computed tomography lymphography in predicting axillary lymph node metastasis.
    Ou X; Zhu J; Qu Y; Wang C; Wang B; Xu X; Wang Y; Wen H; Ma A; Liu X; Zou X; Wen Z
    BMC Med Imaging; 2021 Dec; 21(1):193. PubMed ID: 34911489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of sentinel lymph node metastasis status in predicting the presence of residual disease in the non-sentinel lymph node of breast cancer patients].
    Yang B; Yang L; Zuo WS; Ge WK; Wang YS; Zheng G; Zheng MZ; Yu ZY
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1072-5. PubMed ID: 23902839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer larger than 2.5 cm with tumor-free radioisotope-hot sentinel nodes has higher risk of non-hot axillary lymph node metastasis.
    Liu YL; Kuo WL; Lo YF; Tsai HP; Shen SC; Yu CC; Chou HH; Chu CH; Chen SC
    Biomed J; 2022 Apr; 45(2):396-405. PubMed ID: 35562283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.